{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T21:16:09Z","timestamp":1709068569067},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,26]]},"DOI":"10.7759\/cureus.30724","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T19:17:45Z","timestamp":1666811865000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Imaging Severity Between Vaccinated and Unvaccinated COVID-19 Patients: Perspective of an Indian District"],"prefix":"10.7759","author":[{"given":"Joy","family":"Singhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaurya","family":"Sanjappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipin","family":"Koushal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00644-x","article-title":"Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines","volume":"6","author":"Zhou W","year":"2021","unstructured":"Zhou W, Wang W. Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines. Signal Transduct Target Ther. 2021, 6:226. 10.1038\/s41392-021-00644-x","journal-title":"Signal Transduct Target Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.006","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran WF","year":"2021","unstructured":"Garcia-Beltran WF, Lam EC, St Denis K, et al.. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021, 184:2523. 10.1016\/j.cell.2021.04.006","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27697","article-title":"Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review","volume":"94","author":"Chenchula S","year":"2022","unstructured":"Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J Med Virol. 2022, 94:2969-76. 10.1002\/jmv.27697","journal-title":"J Med Virol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2020200047","article-title":"Chest CT severity score: an imaging tool for assessing severe COVID-19","volume":"2","author":"Yang R","year":"2020","unstructured":"Yang R, Li X, Liu H, et al.. Chest CT severity score: an imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging. 2020, 2:e200047. 10.1148\/ryct.2020200047","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-021-00060-3","article-title":"CO-RADS versus CT-SS scores in predicting severe COVID-19 patients: retrospective comparative study","volume":"15","author":"Zayed NE","year":"2021","unstructured":"Zayed NE, Bessar MA, Lutfy S. CO-RADS versus CT-SS scores in predicting severe COVID-19 patients: retrospective comparative study. Egypt J Bronchol. 2021, 15:13. 10.1186\/s43168-021-00060-3","journal-title":"Egypt J Bronchol"},{"key":"ref6","unstructured":"Serum Institute of India. COVISHIELD FAQs. (2022). Accessed: September 20, 2022: https:\/\/www.seruminstitute.com\/health_faq_covishield.php."},{"key":"ref7","unstructured":"Bharat Biotech. COVAXIN: India's first indigenous Covid-19 vaccine. (2022). Accessed: September 20, 2022: https:\/\/www.bharatbiotech.com\/covaxin.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2020200152","article-title":"Radiological Society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA","volume":"2","author":"Simpson S","year":"2020","unstructured":"Simpson S, Kay FU, Abbara S, et al.. Radiological Society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2020, 2:e200152. 10.1148\/ryct.2020200152","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2320","article-title":"Covid-19 vaccination: evidence of waning immunity is overstated","volume":"374","author":"Scott J","year":"2021","unstructured":"Scott J, Richterman A, Cevik M. Covid-19 vaccination: evidence of waning immunity is overstated. BMJ. 2021, 374:n2320. 10.1136\/bmj.n2320","journal-title":"BMJ"},{"key":"ref10","unstructured":"World Health Organization. The Oxford\/AstraZeneca (chadox1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know. (2022). Accessed: September 20, 2022: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know."},{"key":"ref11","unstructured":"World Health Organization. The Bharat Biotech BBV152 COVAXIN vaccine against COVID-19: what you need to know. (2022). Accessed: September 20, 2022: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-bharat-biotech-bbv152-covaxin-vaccine-against-covid-19-what-...."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson OJ","year":"2022","unstructured":"Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022, 22:1293-302. 10.1016\/S1473-3099(22)00320-6","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin JM","year":"2020","unstructured":"Jin JM, Bai P, He W, et al.. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020, 8:152. 10.3389\/fpubh.2020.00152","journal-title":"Front Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00341-w","article-title":"Coronavirus: why men are more vulnerable to Covid-19 than women?","volume":"2","author":"Bwire GM","year":"2020","unstructured":"Bwire GM. Coronavirus: why men are more vulnerable to Covid-19 than women?. SN Compr Clin Med. 2020, 2:874-6. 10.1007\/s42399-020-00341-w","journal-title":"SN Compr Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-021-00410-2","article-title":"Sex differences in the immune response to acute COVID-19 respiratory tract infection","volume":"12","author":"Qi S","year":"2021","unstructured":"Qi S, Ngwa C, Morales Scheihing DA, et al.. Sex differences in the immune response to acute COVID-19 respiratory tract infection. Biol Sex Differ. 2021, 12:66. 10.1186\/s13293-021-00410-2","journal-title":"Biol Sex Differ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Zheng Z","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, et al.. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020, 81:e16-25. 10.1016\/j.jinf.2020.04.021","journal-title":"J Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.777070","article-title":"Impact of age and sex on COVID-19 severity assessed from radiologic and clinical findings","volume":"25","author":"Statsenko Y","year":"2022","unstructured":"Statsenko Y, Al Zahmi F, Habuza T, et al.. Impact of age and sex on COVID-19 severity assessed from radiologic and clinical findings. Front Cell Infect Microbiol. 2022, 25:777070. 10.3389\/fcimb.2021.777070","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006434","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Romero Starke K","year":"2021","unstructured":"Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health. 2021, 6:e006434. 10.1136\/bmjgh-2021-006434","journal-title":"BMJ Glob Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00698-1","article-title":"Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications","volume":"35","author":"Levin AT","year":"2020","unstructured":"Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020, 35:1123-38. 10.1007\/s10654-020-00698-1","journal-title":"Eur J Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02058-6","article-title":"Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence","volume":"19","author":"Treskova-Schwarzbach M","year":"2021","unstructured":"Treskova-Schwarzbach M, Haas L, Reda S, et al.. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021, 19:212. 10.1186\/s12916-021-02058-6","journal-title":"BMC Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118769-comparison-of-imaging-severity-between-vaccinated-and-unvaccinated-covid-19-patients-perspective-of-an-indian-district","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:47Z","timestamp":1707507827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118769-comparison-of-imaging-severity-between-vaccinated-and-unvaccinated-covid-19-patients-perspective-of-an-indian-district"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.30724","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}